The largest database of trusted experimental protocols

8 protocols using anti cd62l mel 14

1

Comprehensive Immune Cell Phenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
After anesthesia, blood was collected via retro-orbital bleeding using sterile capillary tubes (Paul Marienfeld GmbH & Co. KG., Lauda-Königshofen, Germany). The blood samples (50 μL) were stained using fluorescence-activated cell sorting (FACS) antibodies at 4°C for 20 min; then, the red blood cells (RBCs) were removed using RBC lysis buffer (Sigma-Aldrich). The samples were washed once with FACS buffer (phosphate-buffered saline [PBS] with 1% bovine serum albumin [BSA] and 20 mM ethylenediaminetetraacetic acid) and fixed using 4% PFA. Additionally, lymphocytes (1×106) from the spleen and thymus were incubated with FACS antibodies at 4°C for 20 min. The cells were rinsed once with FACS buffer and fixed using 4% PFA. Cells were then analyzed using flow cytometry (BD FACS VerseTM; BD Biosciences, San Jose, CA, USA), and FlowJo software (BD Biosciences) was used for data analysis. FACS antibodies anti-CD3 (145-2C11), anti-CD4 (RM4-5, GK1.5), anti-CD8 (53-6.7), anti-CD44 (IM7), anti-CD25 (3C7), anti-CD45R/B220 (RA3-6B2), and anti-T cell receptor (TCR)-β (H57-597) were purchased from BD Biosciences. Anti-CD3 (17A2) antibody was purchased from BioLegend (San Diego, CA, USA). Anti-CD8 (5H10) and anti-CD62L (MEL-14) were purchased from Invitrogen (Carlsbad, CA, USA).
+ Open protocol
+ Expand
2

Multiparametric Flow Cytometry of Murine Lymphoid Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-cell suspensions were prepared from the thymus and spleens of Paxbp1 cKO and control mice. For cell surface marker staining, 2 million cells were incubated with the fluorescent antibody mixture at 4°C for 30 min, washed with PBS, and then analyzed by FACS. For intracellular staining, cells were stained with appropriate surface markers, then fixed and stained with antibodies according to the manufacturer’s protocol for the Cyto-Fast™ Fix/Perm Buffer Set (BioLegend, 428703). Zombie Violet™ Fixable Viability Kit (Biolegend, 423113) or 7-AAD (BD, 420404) was used to mark dead cells. The Backman Coulter CytoFLEX S (Backman) was used for the flow cytometric analysis. For cell sorting, thymocytes were isolated and stained with surface markers as indicated above. Then labeled cells were resuspended in FACS buffer (1% FBS + 2 mM EDTA, 25 mM HEPES in PBS). DN, ISP, DP, and SP thymocytes were sorted on an FACSAria III (BD Biosciences).
The following antibodies were used: anti-CD4 (RM-5), anti-CD8 (53–6.7), anti-TCRβ (H57–597), anti-CD44 (IM7), anti-CD25 (PC61), anti-TCRγ/δ (GL3), anti-CD5 (53–7.3), anti-CD69 (H1.2F3), and anti-CD19 (6D5), all of which were purchased from BioLegend. Anti-CD62L (MEL-14) was purchased from Invitrogen.
+ Open protocol
+ Expand
3

Characterizing OT-I CTL Activation Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Expression of activation‐associated surface molecules on OT‐I CTLs was evaluated on day 3 or 4 post‐transduction or the day that adoptive transfer was performed, which was usually day 6 post‐isolation. Cells were stained with anti‐CD8α (53–6.7, BD Biosciences, San Jose, CA, USA), anti‐CD44 (IM7, BD Biosciences), anti‐CD25 (PC61, BD Biosciences), anti‐CD69 (H1.2F3, BD Biosciences), anti‐CD62L (MEL‐14, eBioscience, Vienna, Austria) and anti‐Vα2 (B20.1, BD Biosciences). Antibodies were used at 1 μg mL−1 in running buffer (5% fetal bovine serum and 2 mm ethylenediaminetetraacetic acid, 0.01% sodium azide in 1 × phosphate‐buffered saline) and the cells were stained for 20 min at 4°C prior to washing two times with running buffer. Cell viability was evaluated using 0.5 μg mL−1 4,6‐diamidino‐2‐phenylindole (Thermo Fisher Scientific) or the LIVE/DEAD Fixable near‐IR (Thermo Fisher Scientific). Data were collected on an LSR Fortessa flow cytometer (BD Biosciences) and analyzed using FlowJo software (TreeStar Inc., Ashland, OR, USA). For fluorescence‐activated cell sorting of medium to high mCherry expressing CTL population, cells were resuspended in FACS buffer (5% fetal calf serum, 2 mm ethylenediaminetetraacetic acid in 1 × phosphate‐buffered saline) and incubated with 4,6‐diamidino‐2‐phenylindole. Cells were either used fresh or cryopreserved according to established methods.85
+ Open protocol
+ Expand
4

Comprehensive Flow Cytometry Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used in flow cytometry with the indicated antibody clones and manufacturers for the mouse experiments: Anti-CD3 (17A2; BD Biosciences), anti-CD19 (6D5; BioLegend), anti-CD11c (clone: N418; Biolegend), anti-CD11b (M1/70; BioLegend), anti-CD49b (DX5; eBioscience), anti-CD25 (PC61; BD Biosciences), anti-CD90.2 (anti-Thy-1.2; 53 2.1; eBioscience), anti-CD11c (N418; eBioscience), anti-ST2 (DIH9; BioLegend), anti-Siglec-F (clone: E50-2440; Biolegend) anti-CD4 (RM4-5; BD Biosciences), anti-IL-13 (ebio13A, eBioscience), anti-Foxp3 (FJK-16S; eBioscience), anti-CD62L(MEL-14; eBioscience), LGR6 (17658-1-AP; Proteintech). Flow cytometric data acquisition was performed on an LSRFortessa flow cytometer (BD Biosciences), and the data analyzed using FlowJo software version 10.3 (Tree Star). The gating strategy is provided in SI Appendix, Fig. S7 for populations analyzed.
+ Open protocol
+ Expand
5

Multiparametric Flow Cytometry of Lymphoid Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single‐cell suspensions from mLNs, Peyer's patches, brachial LNs, and spleen were generated by mechanical disruption through a 70 μm cell strainer into MACS buffer (5% FBS, 500 mL PBS and 0.05M EDTA [Gibco]). Nonspecific binding was blocked with normal rat serum (Sigma) and rat anti‐mouse CD16/CD32 Fc block (2.4G2, BD Biosciences) for 20 min at 4°C. The following antibodies were used: anti‐CD19 (1D3), anti‐CD138 (281‐2), anti‐B220 (RA3‐6B2), anti‐IgD (11‐26c.2a), anti‐CD45 (30‐F11), anti‐CD45.1 (A20), anti‐CD45.2 (104) (BioLegend), anti‐CD62L (MEL‐14) (eBioscience), anti‐CD69 (H1.2F3), anti‐CD4 (RM4‐4), anti‐CD8α (53‐6.7), anti‐TCRβ (H57‐597), and PI (P4864‐10ML, Sigma‐Aldrich) was used to assess cellular viability. The CellTrace™ Violet Cell Proliferation Kit was used according to the manufacturer's protocol for in vitro labeling of total splenocytes (C34557, Invitrogen by Thermo Fisher Scientific).
Data acquisition was performed using an LSRII cytometer and DIVA software (BD Bioscience). The analysis was performed using FlowJo software 10 (Treestar Inc).
+ Open protocol
+ Expand
6

Multiparameter Flow Cytometry Panel

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used in flow cytometry:
Anti-CD3 (17A2; BD Biosciences), anti-CD19 (6D5 BioLegend), anti-CD11b Pacific Blue (M1/70; BioLegend), anti-CD49b(DX5; eBioscience), anti-CD25 APC (PC61; BD Biosciences) ; anti-CD90.2 (anti-Thy-1.2; 53-2.1; eBioscience); CD11c (N418; eBioscience); and anti-ST2(Biolegend), Anti-CD4 (RM4-5, BD Biosciences), Foxp3(FJK-16S, eBioscience,), anti-CD62L(MEL-14, eBioscience), anti-IL-13(ebio13A, eBioscience), and anti IL-5 (TRFK5, BioLegend).
+ Open protocol
+ Expand
7

Flow Cytometric Analysis of Spleen Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometric analysis was carried out on the spleens of the indicated animals. Spleens were passed through a 100μm cell strainer (Corning) and the red cells lysed. Samples were resuspended, FC receptors blocked (2.4G2, eBioscience) and surface antigens stained in HBSS (Life Technologies) alone or PBS (Life technologies) plus 0.5% (w/v) BSA (Sigma). The Foxp3 Transcription Factor Staining Buffer Set (eBioscience) was used for intracellular staining. The following stains and antibodies were used: Live/dead (Life Technologies), anti-CD4 (GK1.5, Tonbo Biosciences), anti-CD8 (53-67, Tonbo Bioscience), anti-CD11c (N418, eBioscience), anti-CD19 (6D5, eBioscience), anti-CD25 (PC61.5, eBioscience), anti-CD40L (MR1, eBioscience), anti-CD44 (IM7, eBioscience), anti-CD62L (MEL14, eBioscience), anti-CXCR5 (2G8, BD Bioscience), anti-FoxP3 (FJK-16s, eBioscience), PNA (Vector Laboratories), anti-GL7 (GL-7, eBioscience), anti-ICOS (7E.17G9, eBioscience), anti-IgD (11-26c, eBioscience), anti-IgM (eb121-15F9), anti-PD1 (J43, eBioscience), anti-DR3 (BAF2437, R&D) and anti-TL1A (Tan2-2, University of Southampton [19 (link)]). Samples were run for analysis on a BD FACSVerse and sorted on a BD FACS Aria II. Flow cytometrey data was analyzed with Flow Jo V9.
+ Open protocol
+ Expand
8

Flow Cytometric Analysis of Activated Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell surface staining was performed using the following antibodies: anti-CD11b (M1/70, Miltenyi Biotec), anti-CD11c (N418, BioLegend) anti-CD3 (17A2, eBioscience), anti-CD49b (DX5, eBioscience), anti-CD69 (H1.2 F3, eBioscience), anti-CD86 (GL-1, BioLegend), anti-MHC-II (M5/114.15.2, Miltenyi Biotec), anti-NK1.1 (PK136, BD Bioscience). Dead cells were excluded from analysis (positive for fixable viability dye, eBioscience). For detection of activated T cells splenocytes were stained with anti-CD4 (GK1.5, eBioscience), anti-CD8 (53–6.7, eBioscience), anti-CD43 (1B11, BioLegend) and anti-CD62L (MEL-14, eBioscience). Intracellular IFN-γ (XMG1.2, Miltenyi Biotec), IL-2 (JES6-5H4, Miltenyi Biotec) and TNF-α (MP6-XT22, BioLegend) staining was performed as described [28 (link),29 (link)]. Data were acquired on LSR II flow cytometer (BD Bioscience) and analyses were performed using FACSDiva (BD Bioscience) and Flow Jo (Tree Star, USA) software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!